Key result
Multiplex ligation-dependent probe amplification successfully identified DMD gene exon deletions in 4 out of 6 Rwandan patients with muscular dystrophy phenotypes and 1 out of 6 female carrier relatives.
Why the study?
Can multiplex ligation-dependent probe amplification (MLPA) effectively detect dystrophin (DMD) gene mutations in Rwandan patients with Duchenne and Becker muscular dystrophies?
Observational (n=12)
Can multiplex ligation-dependent probe amplification (MLPA) effectively detect dystrophin (DMD) gene mutations in Rwandan patients with Duchenne and Becker muscular dystrophies?
The MLPA assay can be successfully implemented for the genetic diagnosis of Duchenne and Becker muscular dystrophies in low-income countries.
Answers are grounded in this paper and cite their sources.
MLPA may support DMD genetic diagnosis in low-income settings; extends evidence to Rwandan patients but leaves validation open.
Duchenne and Becker muscular dystrophies are the most common clinical forms of muscular dystrophies. They are genetically X-linked diseases caused by a mutation in the dystrophin (DMD) gene. A genetic diagnosis was carried out in six Rwandan patients presenting a phenotype of Duchenne and Becker muscular dystrophies and six asymptomatic female carrier relatives using multiplex ligation-dependent probe amplification (MLPA). Our results revealed deletion of the exons 48-51 in one patient, an inherited deletion of the exons 8-21 in two brothers and a de novo deletion of the exons 46-50 in the fourth patient. No copy number variation was found in two patients. Only one female carrier presented exon deletion in the DMD gene. This is the first cohort of genetic analysis in Rwandan patients affected by Duchenne and Becker muscular dystrophies. This report confirmed that MLPA assay can be easily implemented in low-income countries.
No takes yet. Share an insight, caveat, or question.
Uwineza et al. (2013) conducted an observational in Duchenne and Becker muscular dystrophies (n=12). Multiplex ligation-dependent probe amplification (MLPA) was evaluated on Detection of exon deletions/mutations in the DMD gene. Multiplex ligation-dependent probe amplification successfully identified DMD gene exon deletions in 4 out of 6 Rwandan patients with muscular dystrophy phenotypes and 1 out of 6 female carrier relatives.
Synapse has enriched 10 related papers. Consider them for comparative context: